IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Recent Updates — HCAT

September 8, 2026View Source ↗

Health Catalyst appointed Simeon Kohl as Chief Executive Officer, President, and a Class III director effective September 14, 2026. Kohl succeeds Ben Albert, who resigned from his executive roles and the Board on September 13, 2026, but remains with the company as Chief Business Officer. Kohl’s compensation includes a $600,000 base salary, a target bonus of 100% of base, and an initial grant of 2,747,385 restricted stock units. Albert will receive a prorated annual bonus for fiscal year 2026 based on his tenure in multiple roles. The Board also adopted the Health Catalyst, Inc. 2026 Employment Inducement Incentive Plan, reserving shares for new hires without prior stockholder approval. Health Catalyst is a healthcare intelligence company that provides AI-driven technology and services to help health systems improve clinical, consumer, and cost performance.

August 6, 2026View Source ↗

Health Catalyst completed the divestiture of its VitalWare business to Med-Metrix, LLC on July 31, 2026, receiving a base purchase price of $147 million. The company used the net proceeds and cash on hand to fully repay and terminate its credit facility, retiring approximately $159.9 million in principal plus fees and interest. Concurrently, Health Catalyst reported second quarter 2026 financial results showing total revenue of $70.5 million and an adjusted EBITDA of $9.9 million. The company provided full-year 2026 guidance for total revenue between $246 million and $249 million and adjusted EBITDA between $18 million and $18.5 million. Health Catalyst operates in the healthcare intelligence industry, providing data analytics and technology solutions to help health systems improve clinical and financial performance.

June 4, 2026View Source ↗

Health Catalyst, Inc. has entered into a Unit Purchase Agreement to sell all equity interests of its Vitalware, LLC business to Med-Metrix, LLC for an aggregate base purchase price of $147 million. The transaction is expected to close in the third quarter of 2026, and the company plans to use the net proceeds to repay and terminate its existing senior secured term loan facility.